5-132638098-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_005732.4(RAD50):c.3493A>G(p.Ile1165Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,788 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005732.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| RAD50 | NM_005732.4 | c.3493A>G | p.Ile1165Val | missense_variant | Exon 23 of 25 | ENST00000378823.8 | NP_005723.2 | |
| TH2LCRR | NR_132125.1 | n.357T>C | non_coding_transcript_exon_variant | Exon 3 of 3 | ||||
| TH2LCRR | NR_132126.1 | n.342T>C | non_coding_transcript_exon_variant | Exon 2 of 2 | ||||
| TH2LCRR | NR_132124.1 | n.153+60T>C | intron_variant | Intron 2 of 2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| RAD50 | ENST00000378823.8 | c.3493A>G | p.Ile1165Val | missense_variant | Exon 23 of 25 | 1 | NM_005732.4 | ENSP00000368100.4 | ||
| ENSG00000283782 | ENST00000638452.2 | c.3196A>G | p.Ile1066Val | missense_variant | Exon 25 of 27 | 5 | ENSP00000492349.2 | 
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.0000159  AC: 4AN: 251382 AF XY:  0.0000147   show subpopulations 
GnomAD4 exome  AF:  0.00000410  AC: 6AN: 1461788Hom.:  0  Cov.: 31 AF XY:  0.00000413  AC XY: 3AN XY: 727200 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome    Uncertain:2 
The p.I1165V variant (also known as c.3493A>G), located in coding exon 23 of the RAD50 gene, results from an A to G substitution at nucleotide position 3493. The isoleucine at codon 1165 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1165 of the RAD50 protein (p.Ile1165Val). This variant is present in population databases (rs765807869, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RAD50-related conditions. ClinVar contains an entry for this variant (Variation ID: 231267). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RAD50 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at